Rochem International is pleased to announce that our strategic manufacturing partner, Jiangsu Willing BioTech Co., Ltd., (Willing) has successfully passed a US FDA inspection in August 2019 with no 483 observations. Rochem’s Regulatory and Compliance department has...

Rochem continues to expand its sales and distribution ability by opening its first sales office in Brazil. Commenting on the expansion, Matt Thiel, President of Rochem said, “With Brazil being in the top three countries for both cattle and poultry production, it is a...

Shandong Shengli Bioengineering passes US FDA inspection with Zero-483 山东胜利生物0-483顺利通过FDA检查 “No findings need to be put on Form 483”. This was the conclusion on July 25, 2019 by the US FDA investigator at the wrap-up meeting after the 4 day general GMP inspection of...